Enko Chem discovers and develops novel products for farmers to protect their crops from pests and diseases. Their proprietary technology platform represents a revolutionary approach to rapidly discover safe and economical solutions that are needed to ensure sustainable food production.
It was founded in 2017 and headquartered in Woburn, Massachusetts.
Oxitec is a biotechnology company focused on developing environmentally friendly solutions for controlling insect pests that transmit diseases and damage crops. Founded in 2002 and based in Oxford, United Kingdom, the company utilizes proprietary technology derived from research at the University of Oxford. This technology enhances the traditional Sterile Insect Technique (SIT) by integrating genetics and molecular biology, making it more cost-effective and safe for a wider range of insect pests. Oxitec offers various genetically modified strains, including Aedes aegypti and Aedes albopictus, which target disease-carrying mosquitoes, as well as strains for agricultural pests like the Diamondback moth and Pink bollworm. These innovations aim to provide targeted, non-toxic, and scalable pest control solutions that protect public health, agricultural productivity, and ecosystems. The company also operates a mosquito production facility in Piracicaba, Brazil, contributing to its global efforts in pest management.
Yemaachi Biotechnology uses cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies for lowering the economic burden of cancer.
Brightseed, Inc. is a biotechnology company that specializes in discovering clinically beneficial molecules found in plants through its innovative Forager platform. Founded in 2017 and based in San Francisco, California, the company employs artificial intelligence and machine learning algorithms to screen plant genes, identifying the most effective sources for addressing various health conditions. By uncovering naturally occurring compounds with potential health benefits, Brightseed aims to enhance the quality of life and support chronic disease management. The company’s mission is to strengthen the connection between people and plants, ultimately facilitating a healthier future for individuals and communities.
Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.
Provivi Inc. develops biopesticides for agriculture, commercial, household, and public health pest management. It develops research quantities of carbene/nitrene transferase enzymes that activate diazo and azide compounds to generate iron-carbenoids and iron-nitrenoids through a mode of activation. The company also develops a biocatalysis and fermentation technology, which is based on biocatalysts that enable efficient synthesis of biopesticides. Its technology has applications in industries, such as pharmaceuticals, nutrition, flavors, and fragrances. The company offers its products through distributors worldwide. Provivi Inc. was incorporated in 2012 and is based in Santa Monica, California.
Atomwise Inc. is a deep learning AI technology for structure-based small molecule drug discovery. Atomwise performs hundreds of projects per year in partnership with some of the world’s largest pharmaceutical and agrochemical companies, as well as more than 200 universities and hospitals in 40 countries. Its speed and accuracy make it the most advanced technology for small molecule binding affinity prediction. AtomNet, its AI platform built for drug discovery contains more than 16 billion molecules for virtual screening.
Enko Chem discovers and develops novel products for farmers to protect their crops from pests and diseases. Their proprietary technology platform represents a revolutionary approach to rapidly discover safe and economical solutions that are needed to ensure sustainable food production.
It was founded in 2017 and headquartered in Woburn, Massachusetts.
Techlets is a provider of a suite of products in the AI-driven MarTech (Marketing Technology). Core product is, Walee - an everyday trade app which enables businesses looking to sell online, and social influencers looking to work with businesses, connect, contract, collaborate and pay each other through an AI-driven matchmaking and financial services engine. Walee has Pakistan's largest and fastest growing influencer network.
Making nature accessible and affordable for a growing society.It is estimated that the world’s population will increase by more than 35% by 2050, reaching 9 billion people. Crop production will need to more than double in order to feed these people and meet the consumer needs of a developing world. With very little land remaining for agricultural expansion, they as a society need to find ways to maximize the use of their world’s resources. Plants produce a variety of rare natural products which are used in their daily lives as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals and agricultural chemicals. They strive to reduce their dependence on land- and resource-intensive practices by recreating natural processes through biotechnology.
CropIn is a leading AI and Data-led agri-tech organization that provides SaaS solutions to agribusinesses globally. CropIn’s unique suite of products enables various stakeholders in the agri-ecosystem to adopt and drive digital strategy across their operations. Using cutting-edge technology like big data analytics, artificial intelligence, machine learning, and remote sensing, CropIn creates an interconnected network of all these stakeholders at different levels of the agriculture ecosystem, enabling clients to analyze and interpret data to derive real-time actionable insights on standing crop. Businesses can thus leverage technology to effectively drive their initiatives around Digitization, Predictability, Compliance, Sustainability and Traceability. With the vision to ‘maximize per acre value’ and the mission to ‘make every farm traceable’, CropIn adds value to agri-businesses by increasing efficiency, scaling productivity, and strengthening sustainability across the board. Thus far, CropIn has digitized over 5.5 million acres of farmland and enriched the lives of nearly 2.1 million farmers, while gathering data on 380+ crops and 3,600+ crop varieties in 46+ countries on 6 continents.
Oxitec is a biotechnology company focused on developing environmentally friendly solutions for controlling insect pests that transmit diseases and damage crops. Founded in 2002 and based in Oxford, United Kingdom, the company utilizes proprietary technology derived from research at the University of Oxford. This technology enhances the traditional Sterile Insect Technique (SIT) by integrating genetics and molecular biology, making it more cost-effective and safe for a wider range of insect pests. Oxitec offers various genetically modified strains, including Aedes aegypti and Aedes albopictus, which target disease-carrying mosquitoes, as well as strains for agricultural pests like the Diamondback moth and Pink bollworm. These innovations aim to provide targeted, non-toxic, and scalable pest control solutions that protect public health, agricultural productivity, and ecosystems. The company also operates a mosquito production facility in Piracicaba, Brazil, contributing to its global efforts in pest management.
Ricult Inc. is an online marketplace that connects farmers with input suppliers and crop buyers, aiming to improve the livelihoods of smallholder farmers in developing countries. Founded by MIT alumni in 2015, the company operates in Thailand and Pakistan, providing a platform that helps farmers procure essential resources such as crops, fertilizers, and micro-nutrients. Utilizing credit scoring algorithms and predictive psychometric tools, Ricult assesses farmers' creditworthiness to facilitate access to loans and farm inputs tailored to their needs. The platform also employs geographic information systems (GIS), remote sensing, soil mechanics, and weather studies to recommend inputs that can enhance crop yields. Headquartered in Boston, Massachusetts, Ricult is recognized as a social enterprise dedicated to lifting farmers out of poverty while engaging in a multi-billion dollar market.
Stellapps designs dairy management software applications that leverage the power of technology to improve dairy supply chain parameters. The company's applications leverage the Internet of Things (IoT), big data, cloud, mobility and data analytics to improve agri-supply chain parameters, including milk production, milk procurement, cold chain animal insurance and farmer payments, enabling dairy farms, dairy farmers and cooperatives to maximize profits while minimizing effort.
Making nature accessible and affordable for a growing society.It is estimated that the world’s population will increase by more than 35% by 2050, reaching 9 billion people. Crop production will need to more than double in order to feed these people and meet the consumer needs of a developing world. With very little land remaining for agricultural expansion, they as a society need to find ways to maximize the use of their world’s resources. Plants produce a variety of rare natural products which are used in their daily lives as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals and agricultural chemicals. They strive to reduce their dependence on land- and resource-intensive practices by recreating natural processes through biotechnology.
Ventria Bioscience, Inc. is a biotechnology company based in Fort Collins, Colorado, specializing in the development, manufacturing, and marketing of health and nutrition products. Founded in 1993, the company focuses on human nutrition and therapeutics, offering a range of products that includes lactoferrin and lysozyme glycoproteins, which are utilized for gastrointestinal health and the dietary management of acute diarrhea, as well as for treating topical infections and fungal conditions. Ventria also provides OptiVERO, a specialized cell culture media for vaccine manufacturing, and operates a BioShare program that grants researchers access to recombinant proteins and peptides for various research applications. The company leverages its patented ExpressTec technology, which enhances recombinant protein yield through a plant-based manufacturing process, enabling the development of new biotherapeutics, vaccines, and other biomanufacturing reagents.
Boragen Inc. is a biotechnology company based in Durham, North Carolina, that specializes in designing and developing multifunctional small molecule boron solutions for applications in crop protection, animal health, and human health. Founded in 2015, the company focuses on creating next-generation fungicides through its synthetic chemistry platforms, which aim to promote sustainable farming practices. Boragen's product pipeline includes BAG8, a boron-based multisite fungicide, and BN2266, which targets mRNA processing as a crop protection fungicide. Additionally, the company is developing a dual-function nematicide-fungicide designed for root protection and endo-parasiticides that address resistance challenges. Through its innovative approach, Boragen seeks to enhance agricultural efficiency while minimizing chemical usage.
Ricult Inc. is an online marketplace that connects farmers with input suppliers and crop buyers, aiming to improve the livelihoods of smallholder farmers in developing countries. Founded by MIT alumni in 2015, the company operates in Thailand and Pakistan, providing a platform that helps farmers procure essential resources such as crops, fertilizers, and micro-nutrients. Utilizing credit scoring algorithms and predictive psychometric tools, Ricult assesses farmers' creditworthiness to facilitate access to loans and farm inputs tailored to their needs. The platform also employs geographic information systems (GIS), remote sensing, soil mechanics, and weather studies to recommend inputs that can enhance crop yields. Headquartered in Boston, Massachusetts, Ricult is recognized as a social enterprise dedicated to lifting farmers out of poverty while engaging in a multi-billion dollar market.
Danforth Technology Company (DTC) is a venture builder based in St. Louis, Missouri, and operates as a subsidiary of the Donald Danforth Plant Science Center. Its primary role is to facilitate the early-stage development of startup companies that leverage technologies developed by the Center's scientists. DTC focuses on moving scientific discoveries into the marketplace more efficiently by providing intellectual property development, licensing, and entrepreneurship support. The company also offers seed funding and early management assistance to promising startups, enhancing the potential for innovation in plant science and contributing to broader societal goals such as improving human health and environmental sustainability.
AgBiome, LLC is a biotechnology company based in Durham, North Carolina, that focuses on developing innovative biological products for the agriculture industry. Founded in 2012, AgBiome utilizes advanced genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and crop yields. The company manufactures fungicides to protect crops from soil-borne and foliar diseases while also employing a platform that captures and screens diverse microbes for their effectiveness against insects, diseases, and nematodes. AgBiome collaborates with leading agricultural firms to accelerate its discovery process and deliver solutions that address critical challenges in global food production. With a workforce of approximately 87 employees and a state-of-the-art laboratory and greenhouse facility in the Research Triangle Park, AgBiome aims to provide sustainable and effective solutions for farmers facing significant agricultural issues.
Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product candidates from discovery to the clinic with improved success and lower cost. Our services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. Batavia Biosciences has successfully worked on viral and bacterial vaccines, recombinant proteins, antibodies and gene therapy products. Unique technologies such as STEP® protein expression technology and SCOUT® high throughput process technology accelerate timelines and reduce costs.
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California. The company specializes in advancing crop nutrition through a deep understanding of the microbiome. By leveraging engineering principles and data science, Pivot Bio develops innovative solutions that utilize naturally occurring microbes to enhance crop yield and quality. Their proprietary ON Technology aims to provide essential nutrients to crops, specifically focusing on enabling microbes to fix and supply nitrogen for corn. This approach seeks to offer a sustainable alternative to traditional chemical fertilizers and pesticides, helping farmers improve their yields while addressing the nutritional needs of the growing global population. Through collaboration and communication, Pivot Bio is dedicated to transforming agricultural practices and contributing to a healthier planet.
Atreca, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on discovering and developing antibody-based immunotherapeutics for various solid tumors. Its lead product candidate, ATRC-101, is a monoclonal antibody currently in clinical development, which demonstrates a unique mechanism of action and targets derived from antibodies identified through Atreca's innovative discovery platform. ATRC-101 has shown in vitro reactivity with a significant majority of cancer samples, including those from ovarian, non-small cell lung, colorectal, and breast cancer patients. Additionally, the company has established a strategic research collaboration with Merck Sharp & Dohme Corp. to identify antigenic targets of select antibodies with potential applications in oncology. Founded in 2010, Atreca aims to advance its therapies to improve treatment options for cancer patients.
AgBiome, LLC is a biotechnology company based in Durham, North Carolina, that focuses on developing innovative biological products for the agriculture industry. Founded in 2012, AgBiome utilizes advanced genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and crop yields. The company manufactures fungicides to protect crops from soil-borne and foliar diseases while also employing a platform that captures and screens diverse microbes for their effectiveness against insects, diseases, and nematodes. AgBiome collaborates with leading agricultural firms to accelerate its discovery process and deliver solutions that address critical challenges in global food production. With a workforce of approximately 87 employees and a state-of-the-art laboratory and greenhouse facility in the Research Triangle Park, AgBiome aims to provide sustainable and effective solutions for farmers facing significant agricultural issues.
Tetragenetics, Inc. is an early-stage biotechnology company meeting the needs of customers who seek a cost-effective alternative platform technology for the production of genetically engineered proteins. Their technology is particularly well suited to the production of eucaryotic membrane and secretory proteins that are difficult to express in conventional systems. Such proteins include vaccine antigens, monoclonal antibodies, and a variety of therapeutic proteins for the treatment and prevention of human and animal disease.
Apeel Sciences, founded in 2012 and headquartered in Santa Barbara, California, specializes in developing plant-derived solutions aimed at reducing food waste and extending the shelf life of fresh produce. The company's innovative products, such as Edipeel and Invisipeel, are designed to protect fruits and vegetables from environmental factors and pre-harvest challenges, effectively doubling their lifespan without the need for refrigeration. By utilizing advances in materials science, Apeel Sciences addresses the global food waste crisis, which amounts to approximately $2.6 trillion annually. The company's technologies not only help to minimize spoilage but also contribute to reducing water and energy consumption while preserving natural ecosystems. Apeel Sciences has gained support from a range of private investors and philanthropic partners, including prominent organizations like the Bill & Melinda Gates Foundation and the Rockefeller Foundation.
Atreca, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on discovering and developing antibody-based immunotherapeutics for various solid tumors. Its lead product candidate, ATRC-101, is a monoclonal antibody currently in clinical development, which demonstrates a unique mechanism of action and targets derived from antibodies identified through Atreca's innovative discovery platform. ATRC-101 has shown in vitro reactivity with a significant majority of cancer samples, including those from ovarian, non-small cell lung, colorectal, and breast cancer patients. Additionally, the company has established a strategic research collaboration with Merck Sharp & Dohme Corp. to identify antigenic targets of select antibodies with potential applications in oncology. Founded in 2010, Atreca aims to advance its therapies to improve treatment options for cancer patients.
Tetragenetics, Inc. is an early-stage biotechnology company meeting the needs of customers who seek a cost-effective alternative platform technology for the production of genetically engineered proteins. Their technology is particularly well suited to the production of eucaryotic membrane and secretory proteins that are difficult to express in conventional systems. Such proteins include vaccine antigens, monoclonal antibodies, and a variety of therapeutic proteins for the treatment and prevention of human and animal disease.